IL129485A0 - Substituted tricyclics - Google Patents

Substituted tricyclics

Info

Publication number: IL129485A0
Authority: IL; Israel
Prior art keywords: substituted tricyclics; tricyclics; substituted
Prior art date: 1998-04-17

Application number

IL12948599A

Other languages

English (en)

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-17

Filing date

1999-04-15

Publication date

2000-02-29

1999-04-15 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2000-02-29 Publication of IL129485A0 publication Critical patent/IL129485A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IL12948599A 1998-04-17 1999-04-15 Substituted tricyclics IL129485A0 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US6232898A	1998-04-17	1998-04-17

Publications (1)

Publication Number	Publication Date
IL129485A0 true IL129485A0 (en)	2000-02-29

Family

ID=22041763

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL12948399A IL129483A0 (en)	1998-04-17	1999-04-15	Substituted tricyclics
IL12948599A IL129485A0 (en)	1998-04-17	1999-04-15	Substituted tricyclics

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
IL12948399A IL129483A0 (en)	1998-04-17	1999-04-15	Substituted tricyclics

Country Status (30)

Country	Link
EP (2)	EP0950657B1 (es)
JP (2)	JP4435330B2 (es)
KR (2)	KR19990083232A (es)
CN (1)	CN1149193C (es)
AR (2)	AR018186A1 (es)
AT (2)	ATE271037T1 (es)
AU (2)	AU753547B2 (es)
BR (2)	BR9902365A (es)
CA (2)	CA2269246C (es)
CO (2)	CO5031247A1 (es)
CZ (2)	CZ137099A3 (es)
DE (2)	DE69917833T2 (es)
DK (1)	DK0950657T3 (es)
DZ (1)	DZ2769A1 (es)
EA (2)	EA002816B1 (es)
ES (2)	ES2222663T3 (es)
HU (2)	HUP9901221A3 (es)
ID (2)	ID23761A (es)
IL (2)	IL129483A0 (es)
NO (2)	NO314400B1 (es)
NZ (3)	NZ335251A (es)
PE (2)	PE20000432A1 (es)
PL (2)	PL332565A1 (es)
PT (1)	PT950657E (es)
SG (2)	SG81976A1 (es)
SI (1)	SI0950657T1 (es)
TR (2)	TR199900853A2 (es)
TW (1)	TWI238160B (es)
YU (2)	YU19199A (es)
ZA (2)	ZA992772B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1011670A4 (en) *	1997-08-28	2004-10-27	Lilly Co Eli	PROCESS FOR TREATING NON-RHUMATOID POLYARTHRITIS
DZ2769A1 (fr) *	1998-04-17	2003-12-01	Lilly Co Eli	Composés tricycliques substitués.
WO2000037022A2 (en) *	1998-12-21	2000-06-29	Eli Lilly And Company	Combination therapy for the treatment of sepsis
ATE350367T1 (de) *	1999-07-19	2007-01-15	Lilly Co Eli	Spla2 inhibitoren
US6706752B1 (en)	1999-07-19	2004-03-16	Eli Lilly And Company	sPLA2 inhibitors
AU2001267825A1 (en)	2000-06-29	2002-01-08	Shionogi And Co., Ltd.	Remedies for cirrhosis
US20040102442A1 (en) *	2000-06-29	2004-05-27	Kohji Hanasaki	Remedies for alzheimer's disease
ES2294003T3 (es) *	2000-06-29	2008-04-01	Anthera Pharmaceuticals, Inc.	Remedios contra el cancer.
JP2004503586A (ja) *	2000-07-14	2004-02-05	イーライ・リリー・アンド・カンパニー	敗血症の治療方法
CA2431028A1 (en) *	2000-12-18	2002-06-27	Ho-Shen Lin	Tetracyclic carbazole derivates and their use as spla2 inhibitors
DE60218155D1 (de) *	2001-03-28	2007-03-29	Lilly Co Eli	Substituierte carbazole als inhibitoren von spla2
AUPS282602A0 (en)	2002-06-07	2002-06-27	Garvan Institute Of Medical Research	Method of inhibiting cell proliferation
DE10249055A1 (de)	2002-10-22	2004-05-06	Bayer Cropscience Ag	2-Phenyl-2-substituierte-1,3-diketone
JO3598B1 (ar)	2006-10-10	2020-07-05	Infinity Discovery Inc	الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
EP1988098A1 (en) *	2007-04-27	2008-11-05	AEterna Zentaris GmbH	Novel Tetrahydrocarbazole Derivatives as Ligands of G-protein Coupled Receptors
AU2009230127B2 (en)	2008-03-26	2011-12-22	Daiichi Sankyo Company, Limited	Novel tetrahydroisoquinoline derivative
WO2009126691A1 (en)	2008-04-09	2009-10-15	Infinity Pharmaceuticals, Inc	Inhibitors of fatty acid amide hydrolase
EP2379538A4 (en)	2009-01-22	2013-01-02	Orchid Res Lab Ltd	HETEROCYCLIC COMPOUNDS AS A PHOSOPHODIESTERASE HEMMER
AU2010234449A1 (en)	2009-04-07	2011-11-03	Infinity Pharmaceuticals, Inc.	Inhibitors of fatty acid amide hydrolase
ES2493916T3 (es)	2009-04-07	2014-09-12	Infinity Pharmaceuticals, Inc.	Inhibidores de hidrolasa de amida de ácidos grasos
WO2011097233A1 (en)	2010-02-03	2011-08-11	Infinity Pharmaceuticals, Inc.	Fatty acid amide hydrolase inhibitors
AR088377A1 (es)	2011-10-20	2014-05-28	Siena Biotech Spa	Proceso para la preparacion de 6-cloro-2,3,4,9-tetrahidro-1h-carbazol-1-carboxamida y compuestos intermedios de esta
CN102816107B (zh) *	2012-08-20	2015-06-03	东南大学	咔唑衍生物及其制备方法与用途
IN2015DN03939A (es) *	2012-11-30	2015-10-02	Ge Healthcare Ltd
RU2015118217A (ru)	2012-11-30	2017-01-11	ДжиИ ХЕЛТКЕР ЛИМИТЕД	Способ кристаллизации трициклических индольных производных
EP3248230B1 (de) *	2015-01-20	2020-05-06	cynora GmbH	Verwendung organischer moleküle in optoelektronischen bauelementen
CN108707104A (zh) *	2018-08-07	2018-10-26	北京恒信卓元科技有限公司	2-氯-1h-咔唑-1,4(9h)-二酮的合成方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3579534A (en) *	1969-05-09	1971-05-18	American Cyanamid Co	Tetrahydrocarbazolecarboxylates
US3979391A (en) *	1972-11-22	1976-09-07	Sterling Drug Inc.	1,2,3,4-Tetrahydrocarbazoles
US3939177A (en) *	1972-11-22	1976-02-17	Sterling Drug Inc.	4-Aminomethyl-9-benzyl-1,2,3,4-tetrahydrocarbazoles
PT95692A (pt) *	1989-10-27	1991-09-13	American Home Prod	Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase
US5420289A (en) *	1989-10-27	1995-05-30	American Home Products Corporation	Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase
CA2110514A1 (en) *	1991-07-05	1993-01-21	Raymond Baker	Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
MY110227A (en) *	1991-08-12	1998-03-31	Ciba Geigy Ag	1-acylpiperindine compounds.
IL109309A (en) *	1993-04-16	2000-06-29	Lilly Co Eli	1-H-indole-3-acetic acid hydrazide SPLA2 inhibitors and pharmaceutical compositions containing them
IL109311A0 (en) *	1993-04-16	1994-07-31	Lilly Co Eli	1H-indole-3-acetamide sPla2 inhibitors
CA2179678A1 (en) *	1995-06-23	1996-12-24	Michael Edward Flaugh	6-substituted-1,2,3,4-tetrahydro-9h-carbazoles and 7-substituted-10h-cyclohepta¬7,6-b\| indoles
BR9612347A (pt) *	1995-12-13	1999-07-13	Lilly Co Eli	Naftil acetamidas como inibidores de spla2
CA2269203A1 (en) *	1996-10-30	1998-05-07	Nicholas James Bach	Substituted tricyclics
EP1007056A1 (en) *	1997-09-26	2000-06-14	Eli Lilly And Company	Method for the treatment of cystic fibrosis
CA2310250A1 (en) *	1997-11-14	1999-05-27	August Masaru Watanabe	Treatment for alzheimer's disease
DZ2769A1 (fr) *	1998-04-17	2003-12-01	Lilly Co Eli	Composés tricycliques substitués.

1999
- 1999-04-14 DZ DZ990069A patent/DZ2769A1/xx active
- 1999-04-15 ID IDP990341D patent/ID23761A/id unknown
- 1999-04-15 IL IL12948399A patent/IL129483A0/xx unknown
- 1999-04-15 ID IDP990340D patent/ID23287A/id unknown
- 1999-04-15 IL IL12948599A patent/IL129485A0/xx unknown
- 1999-04-16 CO CO99022884A patent/CO5031247A1/es unknown
- 1999-04-16 ZA ZA9902772A patent/ZA992772B/xx unknown
- 1999-04-16 AT AT99302967T patent/ATE271037T1/de active
- 1999-04-16 AT AT99302941T patent/ATE268756T1/de not_active IP Right Cessation
- 1999-04-16 YU YU19199A patent/YU19199A/sh unknown
- 1999-04-16 AU AU23819/99A patent/AU753547B2/en not_active Ceased
- 1999-04-16 NZ NZ335251A patent/NZ335251A/xx unknown
- 1999-04-16 AR ARP990101770A patent/AR018186A1/es not_active Application Discontinuation
- 1999-04-16 DE DE69917833T patent/DE69917833T2/de not_active Expired - Lifetime
- 1999-04-16 SG SG9901681A patent/SG81976A1/en unknown
- 1999-04-16 EP EP99302967A patent/EP0950657B1/en not_active Expired - Lifetime
- 1999-04-16 NO NO19991821A patent/NO314400B1/no not_active IP Right Cessation
- 1999-04-16 AR ARP990101771A patent/AR018593A1/es active IP Right Grant
- 1999-04-16 EA EA199900303A patent/EA002816B1/ru not_active IP Right Cessation
- 1999-04-16 DE DE69918590T patent/DE69918590T2/de not_active Expired - Lifetime
- 1999-04-16 NZ NZ507564A patent/NZ507564A/xx unknown
- 1999-04-16 PL PL99332565A patent/PL332565A1/xx not_active Application Discontinuation
- 1999-04-16 EA EA199900301A patent/EA002347B1/ru not_active IP Right Cessation
- 1999-04-16 EP EP99302941A patent/EP0952149B1/en not_active Expired - Lifetime
- 1999-04-16 TR TR1999/00853A patent/TR199900853A2/xx unknown
- 1999-04-16 HU HU9901221A patent/HUP9901221A3/hu unknown
- 1999-04-16 DK DK99302967T patent/DK0950657T3/da active
- 1999-04-16 PE PE1999000314A patent/PE20000432A1/es not_active Application Discontinuation
- 1999-04-16 KR KR1019990013436A patent/KR19990083232A/ko not_active Withdrawn
- 1999-04-16 ZA ZA9902771A patent/ZA992771B/xx unknown
- 1999-04-16 AU AU23817/99A patent/AU753436B2/en not_active Ceased
- 1999-04-16 HU HU9901220A patent/HUP9901220A3/hu unknown
- 1999-04-16 SI SI9930650T patent/SI0950657T1/xx unknown
- 1999-04-16 JP JP15240099A patent/JP4435330B2/ja not_active Expired - Fee Related
- 1999-04-16 BR BR9902365-2A patent/BR9902365A/pt not_active IP Right Cessation
- 1999-04-16 CN CNB991079574A patent/CN1149193C/zh not_active Expired - Fee Related
- 1999-04-16 SG SG9901869A patent/SG81977A1/en unknown
- 1999-04-16 CA CA002269246A patent/CA2269246C/en not_active Expired - Fee Related
- 1999-04-16 ES ES99302941T patent/ES2222663T3/es not_active Expired - Lifetime
- 1999-04-16 TW TW088106130A patent/TWI238160B/zh not_active IP Right Cessation
- 1999-04-16 KR KR1019990013438A patent/KR100586761B1/ko not_active Expired - Fee Related
- 1999-04-16 PL PL99332566A patent/PL332566A1/xx not_active Application Discontinuation
- 1999-04-16 CZ CZ991370A patent/CZ137099A3/cs unknown
- 1999-04-16 JP JP11109629A patent/JPH11322713A/ja not_active Withdrawn
- 1999-04-16 TR TR1999/00843A patent/TR199900843A2/xx unknown
- 1999-04-16 BR BR9901279-0A patent/BR9901279A/pt not_active IP Right Cessation
- 1999-04-16 CZ CZ991369A patent/CZ136999A3/cs unknown
- 1999-04-16 NZ NZ335253A patent/NZ335253A/xx unknown
- 1999-04-16 YU YU18999A patent/YU18999A/sh unknown
- 1999-04-16 PT PT99302967T patent/PT950657E/pt unknown
- 1999-04-16 CO CO99022897A patent/CO5011054A1/es unknown
- 1999-04-16 NO NO19991822A patent/NO312240B1/no not_active IP Right Cessation
- 1999-04-16 PE PE1999000320A patent/PE20000476A1/es not_active Application Discontinuation
- 1999-04-16 ES ES99302967T patent/ES2226286T3/es not_active Expired - Lifetime
- 1999-04-16 CA CA002269262A patent/CA2269262A1/en not_active Abandoned

Also Published As

Publication number	Publication date
BR9901279A (pt)	2000-05-02
DE69918590T2 (de)	2005-07-21
CA2269262A1 (en)	1999-10-17
HU9901220A (hu)	2000-04-28
JP2000026416A (ja)	2000-01-25
DE69917833D1 (de)	2004-07-15
PE20000476A1 (es)	2000-06-02
EP0952149B1 (en)	2004-06-09
ZA992771B (en)	2002-04-18
CO5011054A1 (es)	2001-02-28
ZA992772B (en)	2002-07-16
CZ136999A3 (cs)	1999-11-17
EP0950657A3 (en)	2001-08-16
JP4435330B2 (ja)	2010-03-17
SG81977A1 (en)	2001-07-24
EP0950657B1 (en)	2004-07-14
BR9902365A (pt)	2001-04-24
HU9901221D0 (en)	1999-06-28
DK0950657T3 (da)	2004-11-22
EA199900303A3 (ru)	2000-04-24
NO314400B1 (no)	2003-03-17
PE20000432A1 (es)	2000-05-23
HUP9901220A3 (en)	2001-11-28
ID23287A (id)	2000-04-05
EA199900301A2 (ru)	1999-10-28
TR199900843A2 (xx)	2000-02-21
CN1253948A (zh)	2000-05-24
KR19990083233A (ko)	1999-11-25
DZ2769A1 (fr)	2003-12-01
SI0950657T1 (en)	2005-02-28
NO991821D0 (no)	1999-04-16
CZ137099A3 (cs)	1999-11-17
CA2269246C (en)	2009-08-25
NO991821L (no)	1999-10-18
AU753436B2 (en)	2002-10-17
NO991822L (no)	1999-10-18
KR100586761B1 (ko)	2006-06-08
EA002816B1 (ru)	2002-10-31
NO312240B1 (no)	2002-04-15
CN1149193C (zh)	2004-05-12
HU9901221A (hu)	2000-04-28
EP0950657A2 (en)	1999-10-20
NZ335251A (en)	2000-11-24
DE69917833T2 (de)	2005-07-14
YU19199A (sh)	2002-08-12
EA199900303A2 (ru)	1999-10-28
ES2222663T3 (es)	2005-02-01
KR19990083232A (ko)	1999-11-25
PT950657E (pt)	2004-11-30
CO5031247A1 (es)	2001-04-27
AR018593A1 (es)	2001-11-28
AR018186A1 (es)	2001-10-31
IL129483A0 (en)	2000-02-29
ATE271037T1 (de)	2004-07-15
HU9901220D0 (en)	1999-06-28
TR199900853A3 (tr)	1999-11-22
NZ335253A (en)	2000-11-24
PL332565A1 (en)	1999-10-25
ES2226286T3 (es)	2005-03-16
EA002347B1 (ru)	2002-04-25
NZ507564A (en)	2002-10-25
JPH11322713A (ja)	1999-11-24
EA199900301A3 (ru)	2000-04-24
ATE268756T1 (de)	2004-06-15
DE69918590D1 (de)	2004-08-19
EP0952149A3 (en)	2001-08-16
ID23761A (id)	2000-05-11
AU2381799A (en)	1999-10-28
AU753547B2 (en)	2002-10-24
TR199900853A2 (xx)	1999-11-22
PL332566A1 (en)	1999-10-25
HUP9901221A3 (en)	2001-11-28
NO991822D0 (no)	1999-04-16
SG81976A1 (en)	2001-07-24
EP0952149A2 (en)	1999-10-27
TWI238160B (en)	2005-08-21
CA2269246A1 (en)	1999-10-17
YU18999A (sh)	2002-08-12
AU2381999A (en)	1999-10-28

Publication	Publication Date	Title
IL129483A0 (en)	2000-02-29	Substituted tricyclics
DE59912932D1 (en)	2006-01-19	Arylphenylsubstituierte cyclische ketoenole
DE59912303D1 (en)	2005-08-25	Arylphenylsubstituierte cyclische ketoenole
GB2342193B (en)	2003-06-04	Addition circuitry
PL341642A1 (en)	2001-04-23	Novel macrolydes
DE69904335D1 (en)	2003-01-16	Aminomethylcarbonsäurederivate
DE69835235D1 (en)	2006-08-24	Thermoplastische silikonelastomere
IL129481A0 (en)	2000-02-29	Substituted tricyclics
DE59903023D1 (en)	2002-11-14	Perorale wirkstoff-suspension
DE59914151D1 (en)	2007-02-22	Arylalkanoylpyridazine
SG106035A1 (en)	2004-09-30	Substituted tricyclics
EP1068213A4 (en)	2001-05-02	SILOXANES WITH AMINO-ORGANIC FUNCTIONAL GROUP
DE60042897D1 (en)	2009-10-15	Photovervielfacherröhre
DE69905001D1 (en)	2003-02-27	Koagulationsvorrichtung
DE69904442D1 (en)	2003-01-23	Cyclohexandiol-derivate
DE59904407D1 (en)	2003-04-03	Chromanderivate
PL347397A1 (en)	2002-04-08	Substituted 3-aryl-pyrazoles
GB9816729D0 (en)	1998-09-30	Substituted cyclohexylaminopyrimidines
DE69821502D1 (en)	2004-03-11	Boroskop
DE59900495D1 (en)	2002-01-17	Multimetalloxidmassen
DE59900471D1 (en)	2002-01-10	Inchbremseinrichtung
HUP0102476A3 (en)	2003-08-28	Substituted cyclooctadepsipeptides
DE69902586D1 (en)	2002-09-26	Expandierte ethylencopolymere
DE59905941D1 (en)	2003-07-17	Methoximinophenylessigsäureamide
DE59911094D1 (en)	2004-12-23	Tryptase-inhibitoren